Replay past sessions.


Replay past Regional Interchange in Diabetes (RID) to hear experts from around the world discussing the complexities of T2D, DPP4i, and linagliptin.


Investigating the long-term safety of linagliptin for a broad range of patients.

Sao Paolo, Brazil